Evidence map›Paper›PMID 36931734›Full record

ArticleCold Spring Harbor protocols2023

High-Throughput Mutant Screening via Transposon Sequencing.

Jacob Bourgeois, Andrew Camilli

Open access · bronzeAbstract read
In one paragraph

Article in Cold Spring Harbor protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Microorganisms · 2026
    Article
  3. Review
  4. Article
  5. High-Throughput Mutant Screening inCold Spring Harbor protocols · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jacob BourgeoisDepartment of Molecular Biology and Microbiology, Tufts University, School of Medicine, Boston, Massachusetts 02067, USA.
Andrew CamilliDepartment of Molecular Biology and Microbiology, Tufts University, School of Medicine, Boston, Massachusetts 02067, USA andrew.camilli@tufts.edu.
Tufts University · US

Funding

Phage Resistance in Emergent Vibrio cholerae and Phage Prophylaxis of CholeraR37AI055058 · NIAID · TUFTS UNIVERSITY BOSTON · PI Andrew Camilli · 2020 to 2026
$3.4M
NIAID NIH HHS R37 AI055058
6 · The paper itself

Abstract

Transposon mutagenesis has been the method of choice for genetic screens and selections in bacteria by virtue of the transposon being linked to the disrupted gene, simplifying its identification. Transposon sequencing (Tn-seq) is a high-throughput version of transposon mutant screening, in which massively parallel sequencing is used to simultaneously follow the fitness of all mutants in a complex library. In a single experiment, one can use Tn-seq to interrogate the contribution of all genes of a bacterium to fitness under a condition of interest. Here, we introduce a method to construct a saturating transposon insertion library in Gram-negative bacteria, to capture the transposon junctions

Indexed as

DNA Transposable ElementsHigh-Throughput Nucleotide SequencingGene LibraryMutagenesis, InsertionalDNA Transposable Elements

Identifiers

PMID36931734
PMCPMC10601705
OpenAlexW4327811624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.